Browse by Audience
MEMBER

Update Your Profile
Special Interest Groups (SIG)
Member Spotlights
IASP Connect
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Pain Researcher
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Curricula
Graduate Opportunities
Treatment and Education Resources
Events

PATIENT & CAREGIVER

Resources for Living with Pain
Topic Pages
Free Videos
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner
Make a Donation

I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / Combination GnRH antagonists for endometriosis: Balancing efficacy with side effects.

< BACK TO ARCHIVE


Papers: 17 Sep 2022 - 23 Sep 2022


2022 Sep 20


Cell Rep Med


http://www.ncbi.nlm.nih.gov/pubmed/36130483?dopt=Abstract


3


9

Combination GnRH antagonists for endometriosis: Balancing efficacy with side effects.

Authors

Combination GnRH antagonists for endometriosis: Balancing efficacy with side effects.
Whitaker LHR, Saraswat L, Horne AW
Cell Rep Med. 2022 Sep 20; 3(9):100748.
PMID: 36130483.

Abstract

Endometriosis is a chronic pain condition affecting 1 in 10 women. There is an unmet need for better medical treatments for endometriosis. We spotlight trials of a single preparation combined HRT-GnRH antagonist (Relugolix) by Giudice et al., for endometriosis-associated pain.
Read This Paper